6127 Stock Overview
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥9.55 |
52 Week High | CN¥23.36 |
52 Week Low | CN¥8.10 |
Beta | 0.52 |
1 Month Change | 15.90% |
3 Month Change | -3.83% |
1 Year Change | -56.87% |
3 Year Change | -81.15% |
5 Year Change | n/a |
Change since IPO | -81.01% |
Recent News & Updates
Recent updates
Shareholder Returns
6127 | HK Life Sciences | HK Market | |
---|---|---|---|
7D | 14.9% | 3.7% | 2.4% |
1Y | -56.9% | -63.1% | -8.7% |
Return vs Industry: 6127 exceeded the Hong Kong Life Sciences industry which returned -63.1% over the past year.
Return vs Market: 6127 underperformed the Hong Kong Market which returned -8.7% over the past year.
Price Volatility
6127 volatility | |
---|---|
6127 Average Weekly Movement | 10.6% |
Life Sciences Industry Average Movement | 10.8% |
Market Average Movement | 7.4% |
10% most volatile stocks in HK Market | 15.0% |
10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 6127 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6127's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 2,510 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
6127 fundamental statistics | |
---|---|
Market cap | HK$13.44b |
Earnings (TTM) | -HK$68.27m |
Revenue (TTM) | HK$2.53b |
5.8x
P/S Ratio-214.2x
P/E RatioIs 6127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6127 income statement (TTM) | |
---|---|
Revenue | CN¥2.33b |
Cost of Revenue | CN¥1.43b |
Gross Profit | CN¥897.25m |
Other Expenses | CN¥960.24m |
Earnings | -CN¥62.99m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.084 |
Gross Margin | 38.48% |
Net Profit Margin | -2.70% |
Debt/Equity Ratio | 0.3% |
How did 6127 perform over the long term?
See historical performance and comparison